Wire · opportunities
IQVIA Partners With Medera on Cardiac Gene Therapy Development
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 31 August 2026 · Fusion42 review
IQVIA partners with Medera to accelerate execution of cardiac gene therapy clinical trials in the US, leveraging IQVIA's recruitment, regulatory, and data infrastructure to overcome operational bottlenecks in challenging cardiac gene therapy development.
This Wire brief sits within Fusion42's coverage of Biotech, and 3 sources have reported it.
◆ ◆ The Wire takeaway
You can use IQVIA's expanded clinical trial infrastructure as a lever to speed your cardiac gene therapy trial enrolment and regulatory filings. The FDA Modernization Act's shift to human tissue platforms opens regulatory doors you should move quickly to explore before competition increases.
◆ Coverage
3 sources · 5 Aug 2026
◆ Related on Wire
◆ Topics